Want to join the conversation?
$EW 2Q15 Call: Strong second quarter performance led by underlying sales growth of 18%, significant global TAVR therapy adoption drove our results and also boosted by surgical valve and critical care product lines. During the quarter, we are pleased to receive U.S. approval of SAPIEN 3.
I haven’t seen a drop in banks like this in a long time. Looks like $WFC is still facing pressures from its sales practices scandal..!!
Helping President-elect's America first focus, $WMT set to create 10,000 retail jobs in the US in 2017.
Looks like Trump has his eyes on the $MON and Bayer merger next. He had a meeting with the CEOs and apparently got job promises from them.